Loading…
OSR Health, Inc. is projected to rise to $0.5706 by 2027, a +28% move from its current price of $0.4461. OSRH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.424 | $0.4465 | $0.4702 | +0.09% |
| Aug 6 | $0.4153 | $0.4469 | $0.4809 | +0.18% |
| Aug 7 | $0.4089 | $0.4473 | $0.4893 | +0.27% |
| Aug 8 | $0.4036 | $0.4477 | $0.4965 | +0.36% |
| Aug 9 | $0.3991 | $0.4481 | $0.5031 | +0.44% |
| Aug 10 | $0.3951 | $0.4485 | $0.5091 | +0.53% |
| Aug 11 | $0.3914 | $0.4489 | $0.5148 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3914 | $0.4489 | $0.5148 | +0.62% |
| Week 2 | $0.3721 | $0.4517 | $0.5483 | +1.25% |
| Week 3 | $0.3585 | $0.4545 | $0.5762 | +1.88% |
| Week 4 | $0.3477 | $0.4573 | $0.6015 | +2.52% |
| Week 5 | $0.3387 | $0.4602 | $0.6252 | +3.16% |
| Week 6 | $0.331 | $0.4631 | $0.6477 | +3.80% |
| Week 7 | $0.3243 | $0.4659 | $0.6695 | +4.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OSR Health, Inc. is a healthcare holding company that develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1.
It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical devices and systems. The company was formerly known as OSR Holdings, Inc.
and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.
OSR Health, Inc. (OSRH) is currently trading at $0.43 per share, with a market capitalization of $15.1M, and it ranks at 4686.
The near-term price outlook shows a neutral-to-bullish tone, with a bullish sentiment indicated in the present technical backdrop. The 30-day range spans from $0.3043 to $0.6076, showing notable volatility around the current level.
Over the multi-year horizon, the forecast shows upside potential in several years, including a 2027 average price of $0.5541 and a 2027 max of $0.8192, followed by higher long-run averages such as $0.7465 in 2034 and $1.49 in 2050, with a maximum forecast of $3.43 by 2050. The projected ROI evolves from 0% in 2026 to rising levels, reaching 246.8% by 2050.
The trajectory suggests a longer-run price path that could lead to meaningful upside by the end of the forecast window, though each year's outcome remains an estimate.
A major floor 47.1% below — a decisive break under it would weaken the trend.
The nearest floor, 31.0% below — buyers have tended to step in here.
The nearest ceiling, 8.9% above — a clean break opens room to run.
A major ceiling 66.8% above — clearing it would confirm fresh momentum.
Key OSRH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OSRH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4484 | Sell | $0.4462 | Sell |
| MA 10 | $0.4455 | Buy | $0.4389 | Buy |
| MA 20 | $0.4075 | Buy | $0.4215 | Buy |
| MA 50 | $0.4029 | Buy | $0.4261 | Buy |
| MA 100 | $0.4744 | Sell | $0.4731 | Sell |
| MA 200 | $0.5354 | Sell | $0.8229 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.91 | Neutral |
| Stoch RSI (14) | 35.16 | Neutral |
| CCI (20) | 50.90 | Neutral |
| Williams %R (14) | -30.65 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 6.67 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 69.35 | Neutral |
| TRIX (15) | 0.49 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 56.82 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 0.45 | Sell |
| ADX (14) | 20.27 | Buy |
| ATR (14) | 0.02 | Info |
The 30-day technical picture points to a bullish tilt, with RSI14 at 50 and the price hovering near key moving averages. The 50-day simple moving average stands at $0.4042, while the 200-day simple moving average sits at $0.5359. Support is laid at $0.308 and resistance at $0.486, framing a trading range around the current level.
The 30-day range runs from $0.3043 to $0.6076, highlighting meaningful volatility in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.308 | $0.4461 | $0.632 | 0% | Neutral | |
| $0.4182 | $0.5706 | $0.8407 | +28% | Bullish | |
| $0.3658 | $0.5297 | $0.8315 | +19% | Neutral | |
| $0.3484 | $0.5306 | $0.874 | +19% | Neutral | |
| $0.3212 | $0.5118 | $0.8774 | +15% | Neutral | |
| $0.2857 | $0.4751 | $0.8427 | +7% | Neutral | |
| $0.2748 | $0.4758 | $0.8698 | +7% | Neutral | |
| $0.3264 | $0.5873 | $1.10 | +32% | Bullish | |
| $0.4124 | $0.7707 | $1.48 | +73% | Bullish | |
| $0.3823 | $0.7411 | $1.46 | +66% | Bullish | |
| $0.3986 | $0.8858 | $1.92 | +99% | Bullish | |
| $0.6879 | $1.53 | $3.52 | +243% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.308 | $0.4461 | $0.5318 | +0.00% |
| September 2026 | $0.3644 | $0.4422 | $0.5594 | -0.87% |
| October 2026 | $0.3933 | $0.4837 | $0.624 | +9.38% |
| November 2026 | $0.3945 | $0.4905 | $0.6428 | +1.41% |
| December 2026 | $0.3786 | $0.4756 | $0.632 | -3.05% |
Click any year to see its month-by-month OSRH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OSRH could reach as high as $0.632, with a base case around $0.4461 and support toward $0.308 — roughly 0% from $0.4461. A consolidation phase looks the most probable path here.
Expect OSRH to range from $0.4182 to $0.8407 through 2027. The $0.5706 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Momentum favours further upside here.
The OSRH price prediction for 2028 points to an average of $0.5297 (low $0.3658, high $0.8315) — a potential gain of +19% on today's $0.4461. A consolidation phase looks the most probable path here.
In 2029, OSRH is projected to trade between $0.3484 and $0.874, averaging $0.5306 — a potential gain of +19% from today's $0.4461. That is up 0% on the projected 2028 average. Price action looks broadly range-bound.
OSR Health, Inc.'s 2030 outlook centres on $0.5118, within a $0.3212 to $0.8774 range. That is -4% versus the projected 2029 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, OSRH could reach as high as $0.8427, with a base case around $0.4751 and support toward $0.2857 — roughly +7% from $0.4461. Price action looks broadly range-bound.
Expect OSRH to range from $0.2748 to $0.8698 through 2032. The $0.4758 average target implies a +7% move from current prices. That is up 0% on the projected 2031 average. A consolidation phase looks the most probable path here.
The OSRH price prediction for 2033 points to an average of $0.5873 (low $0.3264, high $1.10) — a potential gain of +32% on today's $0.4461. Momentum favours further upside here.
In 2034, OSRH is projected to trade between $0.4124 and $1.48, averaging $0.7707 — a potential gain of +73% from today's $0.4461. That is up +31% on the projected 2033 average. Buyers look set to stay in control over this stretch.
OSR Health, Inc.'s 2035 outlook centres on $0.7411, within a $0.3823 to $1.46 range. That is -4% versus the projected 2034 average. That marks a +66% change versus current levels. Momentum favours further upside here.
By 2040, OSRH could reach as high as $1.92, with a base case around $0.8858 and support toward $0.3986 — roughly +99% from $0.4461. Buyers look set to stay in control over this stretch.
Expect OSRH to range from $0.6879 to $3.52 through 2050. The $1.53 average target implies a +243% move from current prices. That is up +73% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OSRH today (≈ 2,241.649854 OSRH) could be worth
$3,426.94
+$2,426.94 (+243%) by 2050 · US Dollar
Based on the average projected OSRH price of $1.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OSRHwould be worth at today's price.
$1,000 invested in OSRH on Jul 31, 2025 (≈ 1,453.488323 OSRH) would be worth
$648.4
-$351.6 (-35.2%) today · 0.65× · US Dollar
Based on a OSRH entry price of $0.688 vs. today's $0.4461.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.423 | $1,054.61 | +5.5% |
| 1 month ago | $0.31 | $1,439.03 | +43.9% |
| 3 months ago | $0.637 | $700.31 | -30.0% |
| 6 months ago | $0.559 | $798.03 | -20.2% |
| 1 year ago | $0.688 | $648.4 | -35.2% |
| All time (3.4y) ago | $10.1 | $44.17 | -95.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OSRH forecast.
Our base-case forecast reaches $0.89 around 2050.
Implied market cap at $0.89: $31.26M
Looking out across the multi-year horizon, the forecast shows a mix of neutral and bullish years with meaningful upside in the later years. The 2027 forecast offers an avg of $0.5541 and ROI of 28.9% with bullish sentiment, followed by a string of neutral years such as 2028 (avg $0.5056, ROI 17.6%) and 2029 (avg $0.5111, ROI 18.9%). By 2030 the avg is $0.4979 with ROI 15.8% and neutral sentiment.
The 2033–2035 stretch flips to bullish, with 2033 avg $0.5816 and 2034 avg $0.7465 (ROI 73.6%) and 2035 avg $0.7193 (ROI 67.3%). The long-horizon view strengthens further, with 2040 avg $0.8659 (ROI 101.4%) and 2050 avg $1.49 (ROI 246.8%). These figures imply a potential path to higher prices, culminating in a mean forecast around $1.49 by 2050, but all outcomes are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $0.4979; min $0.3107; max $0.8575; ROI 15.8%.
Forecasts show neutral to bullish signals over time, with a bullish inflection in 2027 (avg $0.5541, ROI 28.9%), and long-run upside to an avg of $1.49 by 2050 (ROI 246.8%). Shorter windows include years with neutral sentiment and positive but smaller ROIs.
Yes. The 2034 max is $1.45 and the 2050 avg is $1.49 with a max of $3.43, indicating the potential to reach or exceed $1 in the forecast window.
Current price $0.43; market cap $15.1M.
Current sentiment is BULLISH; RSI14 is 50; annualized volatility is 100%.
OSR Health, Inc. Community Discussion
0Share your OSR Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.